Novavax signs COVID-19 vaccine supply deal with India#39;s Serum Institute

The Indian drugmaker will have exclusive rights for the vaccine in India during the term of the deal and non-exclusive rights during the "Pandemic Period" in all countries other than those designated by the World Bank as upper-middle or high-income countries.

from Moneycontrol Business News https://ift.tt/2DfpR4T